Concepts (305)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood-Brain Barrier | 15 | 2019 | 37 | 3.140 |
Why?
|
| Brain | 24 | 2021 | 1639 | 1.980 |
Why?
|
| Brain Injuries | 7 | 2019 | 26 | 1.920 |
Why?
|
| Alzheimer Disease | 15 | 2023 | 2062 | 1.840 |
Why?
|
| TDP-43 Proteinopathies | 6 | 2023 | 109 | 1.790 |
Why?
|
| Amyotrophic Lateral Sclerosis | 3 | 2023 | 21 | 1.670 |
Why?
|
| Aging | 17 | 2023 | 1536 | 1.660 |
Why?
|
| Lewy Bodies | 8 | 2023 | 193 | 1.600 |
Why?
|
| Frontotemporal Lobar Degeneration | 3 | 2023 | 29 | 1.600 |
Why?
|
| DNA-Binding Proteins | 8 | 2023 | 254 | 1.500 |
Why?
|
| Olfaction Disorders | 2 | 2021 | 49 | 1.370 |
Why?
|
| Frontotemporal Dementia | 3 | 2023 | 13 | 1.130 |
Why?
|
| Aged, 80 and over | 31 | 2023 | 4670 | 1.050 |
Why?
|
| Cerebral Cortex | 5 | 2021 | 159 | 1.030 |
Why?
|
| Angiopoietin-1 | 6 | 2016 | 6 | 1.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 7 | 2019 | 66 | 1.010 |
Why?
|
| Lewy Body Disease | 3 | 2021 | 97 | 0.950 |
Why?
|
| Male | 44 | 2023 | 14107 | 0.910 |
Why?
|
| Rats | 15 | 2019 | 598 | 0.890 |
Why?
|
| Animals | 22 | 2019 | 3388 | 0.890 |
Why?
|
| Substantia Nigra | 3 | 2021 | 113 | 0.820 |
Why?
|
| Dementia | 5 | 2019 | 526 | 0.820 |
Why?
|
| Cognitive Dysfunction | 5 | 2023 | 1020 | 0.820 |
Why?
|
| Brain Edema | 5 | 2011 | 18 | 0.820 |
Why?
|
| Parkinsonian Disorders | 6 | 2023 | 218 | 0.810 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 110 | 0.780 |
Why?
|
| Humans | 56 | 2023 | 26227 | 0.770 |
Why?
|
| Endothelium, Vascular | 8 | 2005 | 39 | 0.740 |
Why?
|
| Amygdala | 1 | 2021 | 40 | 0.740 |
Why?
|
| Olfactory Bulb | 2 | 2023 | 18 | 0.720 |
Why?
|
| Temporal Lobe | 2 | 2018 | 84 | 0.700 |
Why?
|
| Neocortex | 1 | 2019 | 32 | 0.670 |
Why?
|
| Female | 38 | 2023 | 14499 | 0.650 |
Why?
|
| Immunohistochemistry | 7 | 2017 | 336 | 0.630 |
Why?
|
| Longitudinal Studies | 9 | 2021 | 1342 | 0.620 |
Why?
|
| Angiopoietin-2 | 4 | 2005 | 4 | 0.620 |
Why?
|
| Caveolin 1 | 4 | 2016 | 11 | 0.590 |
Why?
|
| Pituitary Neoplasms | 1 | 2017 | 16 | 0.580 |
Why?
|
| Proteins | 2 | 2011 | 54 | 0.570 |
Why?
|
| Cognition | 7 | 2021 | 1287 | 0.560 |
Why?
|
| Rats, Wistar | 8 | 2019 | 31 | 0.560 |
Why?
|
| Neuroprotective Agents | 1 | 2016 | 51 | 0.510 |
Why?
|
| Memory Disorders | 1 | 2017 | 164 | 0.500 |
Why?
|
| Cerebral Ventricle Neoplasms | 2 | 2013 | 7 | 0.500 |
Why?
|
| Glioma, Subependymal | 2 | 2013 | 6 | 0.500 |
Why?
|
| Neovascularization, Pathologic | 4 | 2005 | 33 | 0.490 |
Why?
|
| Tight Junctions | 4 | 2011 | 23 | 0.490 |
Why?
|
| Aged | 22 | 2023 | 8749 | 0.470 |
Why?
|
| Spinal Cord | 4 | 2018 | 82 | 0.460 |
Why?
|
| Ependymoma | 1 | 2013 | 15 | 0.430 |
Why?
|
| Endothelial Cells | 2 | 2011 | 51 | 0.430 |
Why?
|
| Hippocampus | 1 | 2015 | 260 | 0.430 |
Why?
|
| Blood Vessels | 2 | 2011 | 14 | 0.420 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2023 | 114 | 0.420 |
Why?
|
| Cold Temperature | 4 | 2008 | 13 | 0.400 |
Why?
|
| Brain Diseases | 4 | 2021 | 64 | 0.400 |
Why?
|
| Fibronectins | 5 | 2019 | 21 | 0.400 |
Why?
|
| Autopsy | 5 | 2021 | 340 | 0.390 |
Why?
|
| Parkinson Disease | 5 | 2023 | 826 | 0.390 |
Why?
|
| Arteriolosclerosis | 3 | 2023 | 78 | 0.380 |
Why?
|
| Neuropsychological Tests | 7 | 2023 | 1221 | 0.370 |
Why?
|
| Neurons | 5 | 2013 | 310 | 0.360 |
Why?
|
| Cell Adhesion Molecules | 2 | 2008 | 19 | 0.360 |
Why?
|
| RNA, Messenger | 4 | 2005 | 264 | 0.350 |
Why?
|
| Membrane Proteins | 2 | 2008 | 151 | 0.340 |
Why?
|
| Cognition Disorders | 5 | 2018 | 984 | 0.330 |
Why?
|
| Astrocytes | 1 | 2011 | 132 | 0.330 |
Why?
|
| Disease Progression | 5 | 2019 | 685 | 0.330 |
Why?
|
| Gene Expression Regulation | 2 | 2008 | 234 | 0.320 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 935 | 0.320 |
Why?
|
| Microscopy, Electron | 3 | 2003 | 63 | 0.320 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2007 | 5 | 0.300 |
Why?
|
| Mycosis Fungoides | 1 | 2007 | 6 | 0.300 |
Why?
|
| Horseradish Peroxidase | 4 | 2016 | 4 | 0.300 |
Why?
|
| Muscular Diseases | 1 | 2007 | 14 | 0.300 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2007 | 27 | 0.290 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2023 | 1145 | 0.290 |
Why?
|
| Occludin | 3 | 2016 | 11 | 0.280 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2020 | 33 | 0.280 |
Why?
|
| Cerebrovascular Disorders | 2 | 2023 | 133 | 0.280 |
Why?
|
| Depression | 3 | 2016 | 407 | 0.280 |
Why?
|
| Angiopoietins | 3 | 2011 | 15 | 0.270 |
Why?
|
| Endothelial Growth Factors | 2 | 2002 | 9 | 0.260 |
Why?
|
| Apoptosis | 2 | 2007 | 193 | 0.250 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2005 | 1 | 0.240 |
Why?
|
| Pituitary Gland, Posterior | 1 | 2005 | 1 | 0.240 |
Why?
|
| Disease Models, Animal | 4 | 2011 | 563 | 0.240 |
Why?
|
| Adult | 9 | 2023 | 7437 | 0.240 |
Why?
|
| Locus Coeruleus | 3 | 2013 | 22 | 0.240 |
Why?
|
| Plaque, Amyloid | 2 | 2015 | 141 | 0.230 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2003 | 4 | 0.220 |
Why?
|
| Caveolae | 3 | 2011 | 17 | 0.220 |
Why?
|
| Limbic Encephalitis | 1 | 2023 | 12 | 0.220 |
Why?
|
| Independent Living | 3 | 2023 | 306 | 0.220 |
Why?
|
| Neovascularization, Physiologic | 2 | 2019 | 17 | 0.210 |
Why?
|
| Motor Disorders | 1 | 2023 | 24 | 0.210 |
Why?
|
| Neurofibrillary Tangles | 4 | 2023 | 191 | 0.210 |
Why?
|
| Histocytochemistry | 1 | 2003 | 14 | 0.210 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 67 | 0.210 |
Why?
|
| Cohort Studies | 6 | 2018 | 1841 | 0.210 |
Why?
|
| Cerebrum | 1 | 2023 | 11 | 0.210 |
Why?
|
| Atherosclerosis | 1 | 2023 | 49 | 0.210 |
Why?
|
| Meningitis | 1 | 2022 | 8 | 0.200 |
Why?
|
| Telencephalon | 1 | 2002 | 1 | 0.200 |
Why?
|
| Signal Transduction | 2 | 2016 | 386 | 0.190 |
Why?
|
| Amyloid beta-Peptides | 3 | 2023 | 318 | 0.190 |
Why?
|
| Logistic Models | 3 | 2017 | 365 | 0.190 |
Why?
|
| Rhabdoid Tumor | 1 | 2020 | 2 | 0.180 |
Why?
|
| Late Onset Disorders | 1 | 2020 | 6 | 0.180 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2020 | 9 | 0.180 |
Why?
|
| Rats, Inbred WF | 3 | 2005 | 6 | 0.170 |
Why?
|
| Illinois | 1 | 2020 | 230 | 0.170 |
Why?
|
| Coloring Agents | 2 | 2013 | 12 | 0.160 |
Why?
|
| Capillary Permeability | 3 | 2003 | 26 | 0.160 |
Why?
|
| Headache | 2 | 2017 | 31 | 0.160 |
Why?
|
| Motor Neurons | 1 | 2018 | 17 | 0.160 |
Why?
|
| Comorbidity | 1 | 2020 | 475 | 0.160 |
Why?
|
| Middle Aged | 9 | 2019 | 8585 | 0.160 |
Why?
|
| Movement | 1 | 2018 | 108 | 0.150 |
Why?
|
| Microscopy, Confocal | 2 | 2011 | 85 | 0.150 |
Why?
|
| Age Factors | 1 | 2020 | 749 | 0.150 |
Why?
|
| Growth Hormone-Secreting Pituitary Adenoma | 1 | 2017 | 2 | 0.150 |
Why?
|
| Facial Pain | 1 | 2017 | 5 | 0.150 |
Why?
|
| Brain Infarction | 1 | 2018 | 74 | 0.150 |
Why?
|
| Phosphorylation | 2 | 2016 | 133 | 0.150 |
Why?
|
| Microvessels | 1 | 2017 | 14 | 0.150 |
Why?
|
| Vision Disorders | 1 | 2017 | 21 | 0.150 |
Why?
|
| Linear Models | 1 | 2018 | 239 | 0.140 |
Why?
|
| Time Factors | 4 | 2013 | 1382 | 0.140 |
Why?
|
| Fragile X Syndrome | 1 | 2020 | 192 | 0.140 |
Why?
|
| Fluorescent Dyes | 2 | 2011 | 35 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2011 | 13 | 0.140 |
Why?
|
| Endothelium | 2 | 2011 | 11 | 0.140 |
Why?
|
| Tuberous Sclerosis | 1 | 2017 | 15 | 0.140 |
Why?
|
| Brain Stem | 2 | 2016 | 19 | 0.140 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 94 | 0.140 |
Why?
|
| Hypertension | 3 | 2003 | 222 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor B | 2 | 2009 | 2 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 347 | 0.130 |
Why?
|
| Epidermal Cyst | 1 | 2016 | 5 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 44 | 0.130 |
Why?
|
| Brain Chemistry | 1 | 2016 | 41 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 119 | 0.130 |
Why?
|
| Central Nervous System Cysts | 1 | 2015 | 6 | 0.130 |
Why?
|
| Sphenoid Sinus | 1 | 2015 | 14 | 0.130 |
Why?
|
| Visceral Afferents | 1 | 2015 | 4 | 0.130 |
Why?
|
| Choroid Plexus | 2 | 2007 | 7 | 0.130 |
Why?
|
| Spinal Cord Dorsal Horn | 1 | 2015 | 7 | 0.130 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 67 | 0.120 |
Why?
|
| United States | 1 | 2021 | 1991 | 0.120 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 97 | 0.120 |
Why?
|
| Urinary Incontinence | 1 | 2015 | 22 | 0.120 |
Why?
|
| Sclerosis | 1 | 2015 | 66 | 0.120 |
Why?
|
| Cell Membrane | 2 | 2007 | 82 | 0.120 |
Why?
|
| Multiple System Atrophy | 1 | 2015 | 35 | 0.120 |
Why?
|
| Skull Base Neoplasms | 1 | 2014 | 18 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 2 | 2005 | 30 | 0.120 |
Why?
|
| Pineal Gland | 1 | 2014 | 3 | 0.120 |
Why?
|
| gamma-Tocopherol | 1 | 2014 | 7 | 0.120 |
Why?
|
| alpha-Tocopherol | 1 | 2014 | 10 | 0.110 |
Why?
|
| Glioblastoma | 1 | 2013 | 7 | 0.110 |
Why?
|
| Immunocompetence | 1 | 2013 | 5 | 0.110 |
Why?
|
| Neuroma, Acoustic | 1 | 2013 | 9 | 0.110 |
Why?
|
| Coccidioidomycosis | 1 | 2013 | 6 | 0.110 |
Why?
|
| Quadriplegia | 1 | 2013 | 8 | 0.110 |
Why?
|
| Mesencephalon | 1 | 2013 | 26 | 0.110 |
Why?
|
| Apolipoprotein E4 | 1 | 2015 | 244 | 0.110 |
Why?
|
| alpha-Synuclein | 1 | 2015 | 121 | 0.110 |
Why?
|
| Radiosurgery | 1 | 2013 | 32 | 0.110 |
Why?
|
| Ki-67 Antigen | 1 | 2013 | 16 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 73 | 0.110 |
Why?
|
| Biomarkers | 2 | 2007 | 556 | 0.110 |
Why?
|
| Uterine Neoplasms | 1 | 2013 | 10 | 0.110 |
Why?
|
| Leiomyosarcoma | 1 | 2013 | 21 | 0.110 |
Why?
|
| Psychomotor Disorders | 1 | 2013 | 11 | 0.110 |
Why?
|
| Inflammation | 3 | 2007 | 264 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2013 | 43 | 0.100 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 1735 | 0.100 |
Why?
|
| Neurosurgical Procedures | 1 | 2013 | 125 | 0.100 |
Why?
|
| Blood Proteins | 1 | 2011 | 16 | 0.090 |
Why?
|
| Antibodies | 1 | 2011 | 41 | 0.090 |
Why?
|
| Synapses | 1 | 2011 | 34 | 0.090 |
Why?
|
| Aquaporin 1 | 1 | 2009 | 1 | 0.080 |
Why?
|
| Aquaporin 4 | 1 | 2009 | 7 | 0.080 |
Why?
|
| Matrix Metalloproteinases | 1 | 2009 | 18 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2019 | 1669 | 0.080 |
Why?
|
| Junctional Adhesion Molecules | 1 | 2008 | 1 | 0.080 |
Why?
|
| Receptor, TIE-2 | 2 | 2005 | 2 | 0.080 |
Why?
|
| Sural Nerve | 1 | 2007 | 4 | 0.070 |
Why?
|
| Neural Conduction | 1 | 2007 | 8 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2014 | 303 | 0.070 |
Why?
|
| Peripheral Nerves | 1 | 2007 | 18 | 0.070 |
Why?
|
| Muscle Weakness | 1 | 2007 | 28 | 0.070 |
Why?
|
| Claudin-5 | 1 | 2007 | 3 | 0.070 |
Why?
|
| Calcium | 1 | 2011 | 368 | 0.070 |
Why?
|
| Alleles | 2 | 2020 | 201 | 0.070 |
Why?
|
| Cerebral Arteries | 1 | 2007 | 24 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 90 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2007 | 92 | 0.070 |
Why?
|
| Biopsy | 1 | 2007 | 200 | 0.070 |
Why?
|
| Skin | 1 | 2007 | 103 | 0.070 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2007 | 5 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2007 | 150 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 14 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2005 | 19 | 0.060 |
Why?
|
| Caspases | 1 | 2005 | 26 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2007 | 116 | 0.060 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2005 | 5 | 0.060 |
Why?
|
| Prognosis | 1 | 2007 | 758 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 359 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2013 | 3381 | 0.060 |
Why?
|
| Memory | 2 | 2018 | 299 | 0.060 |
Why?
|
| Gene Expression | 1 | 2005 | 180 | 0.060 |
Why?
|
| Myocardium | 1 | 2004 | 95 | 0.060 |
Why?
|
| Encephalitis | 1 | 2003 | 10 | 0.060 |
Why?
|
| Infarction | 1 | 2023 | 31 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2004 | 135 | 0.050 |
Why?
|
| CpG Islands | 1 | 2003 | 33 | 0.050 |
Why?
|
| Cell Count | 2 | 2013 | 75 | 0.050 |
Why?
|
| Microtomy | 1 | 2003 | 1 | 0.050 |
Why?
|
| Monosaccharides | 1 | 2003 | 1 | 0.050 |
Why?
|
| Serum Albumin, Radio-Iodinated | 1 | 2003 | 1 | 0.050 |
Why?
|
| Lanthanum | 1 | 2003 | 2 | 0.050 |
Why?
|
| Tissue Embedding | 1 | 2003 | 3 | 0.050 |
Why?
|
| Pia Mater | 1 | 2003 | 3 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2003 | 7 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2003 | 4 | 0.050 |
Why?
|
| Pericytes | 1 | 2003 | 7 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2003 | 15 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2003 | 11 | 0.050 |
Why?
|
| Antigens | 1 | 2003 | 7 | 0.050 |
Why?
|
| Vasoconstriction | 1 | 2003 | 15 | 0.050 |
Why?
|
| Peroxidases | 1 | 2003 | 7 | 0.050 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2003 | 17 | 0.050 |
Why?
|
| Capillaries | 1 | 2003 | 11 | 0.050 |
Why?
|
| Basement Membrane | 1 | 2003 | 11 | 0.050 |
Why?
|
| Chemokines | 1 | 2003 | 21 | 0.050 |
Why?
|
| Cats | 1 | 2003 | 29 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2003 | 31 | 0.050 |
Why?
|
| Electrophysiology | 1 | 2003 | 94 | 0.050 |
Why?
|
| Mitotic Index | 1 | 2002 | 3 | 0.050 |
Why?
|
| Mitochondria | 1 | 2003 | 57 | 0.050 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 8 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 40 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2003 | 167 | 0.050 |
Why?
|
| Meninges | 1 | 2022 | 8 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2022 | 19 | 0.050 |
Why?
|
| Macrophages | 1 | 2003 | 105 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 107 | 0.050 |
Why?
|
| Lymphokines | 1 | 2002 | 8 | 0.050 |
Why?
|
| Mice | 2 | 2003 | 1277 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 87 | 0.050 |
Why?
|
| Lumbar Vertebrae | 2 | 2018 | 412 | 0.050 |
Why?
|
| tau Proteins | 1 | 2023 | 225 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2003 | 117 | 0.050 |
Why?
|
| Cranial Fossa, Posterior | 2 | 2014 | 7 | 0.050 |
Why?
|
| Models, Biological | 1 | 2003 | 302 | 0.050 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2020 | 46 | 0.040 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2020 | 118 | 0.040 |
Why?
|
| Decompression, Surgical | 1 | 2020 | 128 | 0.040 |
Why?
|
| Young Adult | 2 | 2015 | 1886 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2020 | 592 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2019 | 132 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2019 | 3365 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2018 | 120 | 0.040 |
Why?
|
| Microglia | 1 | 2018 | 135 | 0.040 |
Why?
|
| Scalp | 1 | 2016 | 5 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 83 | 0.030 |
Why?
|
| Sacrum | 1 | 2015 | 24 | 0.030 |
Why?
|
| Heterozygote | 1 | 2015 | 92 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 335 | 0.030 |
Why?
|
| Cell Nucleus Shape | 1 | 2014 | 3 | 0.030 |
Why?
|
| Cell Shape | 1 | 2014 | 7 | 0.030 |
Why?
|
| Thoracic Vertebrae | 1 | 2015 | 93 | 0.030 |
Why?
|
| Raphe Nuclei | 1 | 2013 | 7 | 0.030 |
Why?
|
| Ventral Tegmental Area | 1 | 2013 | 9 | 0.030 |
Why?
|
| Postmortem Changes | 1 | 2012 | 31 | 0.030 |
Why?
|
| Amyloid | 1 | 2012 | 57 | 0.030 |
Why?
|
| Infant | 1 | 2014 | 520 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2014 | 593 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 253 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 2013 | 300 | 0.020 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2007 | 1 | 0.020 |
Why?
|
| CD59 Antigens | 1 | 2007 | 2 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 11 | 0.020 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2007 | 5 | 0.020 |
Why?
|
| Epithelium | 1 | 2007 | 23 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 51 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2007 | 67 | 0.020 |
Why?
|
| Necrosis | 1 | 2005 | 26 | 0.020 |
Why?
|
| Craniotomy | 1 | 2005 | 20 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 186 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2004 | 20 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2004 | 133 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 317 | 0.010 |
Why?
|
| Gene Library | 1 | 2003 | 6 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 22 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2003 | 38 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 28 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2003 | 77 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2003 | 159 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 311 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2003 | 473 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 419 | 0.010 |
Why?
|
| Adolescent | 1 | 2007 | 2078 | 0.010 |
Why?
|